Abdul Latif Jameel Health, part of international diversified family business Abdul Latif Jameel, and Wellesta Holdings Pte. Ltd., a Singapore headquartered company providing marketing and commercialization support to the healthcare sector in South East Asia, India & partnering in MENA, today announced an important new agreement for the marketing and distribution of the Butterfly iQ+™ point-of-care ultrasound device in The Republic of India.
The innovative Butterfly iQ+™ is the world’s first single probe, whole-body handheld point-of-care ultrasound solution. As part of its new agreement with Abdul Latif Jameel Health, Wellesta will register Butterfly iQ+™ in India and start promoting and selling the product in the country in the fourth quarter of 2022, bringing this technology to a potential 1.2 million registered physicians in the country.
Today, more than 4.7 billion around the world lack access to medical imaging, from underserved communities in the United States to remote areas of Africa. The Butterfly iQ+™ aims to remedy this situation. Fusing semiconductors, artificial intelligence, and cloud technology, Butterfly has made it possible to usher in a new era of medical imaging and with it, healthcare.
This new collaboration will offer greater distribution of Butterfly iQ+™ to physicians in India thereby expanding the capabilities of the practitioners in making informed decisions thereby accelerating access to modern medical care for those who need it most.
Butterfly iQ+™, is revolutionizing medical imaging. It is a hand-held 4 in 1 single probe whole-body innovative point-of-care ultrasound device powered by the world’s only Ultrasound–on-Chip™ technology.
This point of care device with over 20 default pre-sets is compatible with both iOS and Android smart devices and comes complete with battery back, wireless charging, cloud storage, customized app., software, and AI support.
Hailed as potentially the ‘stethoscope of the future’, the Butterfly iQ+™ transforms what can sometimes be complex processes, into one connected and integrated point-of-care ultrasound (POCUS) system to help collect advanced imaging, perform rapid assessments, and guide critical procedures. It allows the sharing of results seamlessly with doctors across the globe to help read and interpret scans.
Speaking about this new collaboration, Mr. Milan Paleja, Chairman and Managing Director, Wellesta, said: “I am very excited to partner with Abdul Latif Jameel Health to market Butterfly iQ+™ in India to bring this breakthrough Ultrasound-on-Chip™ technology in the Butterfly probe to this market. Its versatile, innovative ultrasound solution will assist healthcare professionals to obtain point-of-care ultrasound-driven insights – – across the vast country with a geographically disperse population to improve access to primary healthcare.”
Mr. Paleja added his thanks to deal advisor, Healthark Insights who supported this collaboration with Abdul Latif Jameel Health.
Akram Bouchenaki, Chief Executive Officer, Abdul Latif Jameel Health added: “Abdul Latif Jameel is addressing tangible real-world needs today, for a better tomorrow. We are focused on health care inclusion, accelerating access to modern medical care for those who need it most.
“We believe in realizing the true power of deep local knowledge, relationships, and partnerships to get the very best results for the communities we serve. In India, I am proud to collaborate with Wellesta who share our vision of improving live and lives across the Global South.”
For more information, visit: https://aljhealth.com